(PharmaNewsWire.Com, February 12, 2019 ) The Structural Biology & Molecular Modeling Market report aims to provide a 360-degree view of the market in terms of cutting-edge technology, key developments, drivers, restraints and future trends with impact analysis of these trends on the market for short-term, mid-term and long-term during the forecast period. Further, the report also covers key players profiling with detailed SWOT analysis, financial facts and key developments of products/service from the past three years.
Structural biology & molecular modeling are powerful techniques for analyzing the three dimensional structure of biological macromolecules. Structural biology is the study of the molecular structure and dynamics of biological macromolecules, particularly proteins and nucleic acids, and how alterations in their structures affect their function. Structural biology is based on the principles of molecular biology, biochemistry and biophysics. Drug design companies are investing in modeling projects in which they are able to predict the structure of the newly made drugs and the molecular components that will providing biding sites for them. Thus, these molecular modeling techniques have helped in better understanding of the concept of life.
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter strategies to gain competitive advantage
- Identify and understand important and diverse types of Structural Biology & Molecular Modeling under development
- Develop market entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product's current stage of development, territory and estimated launch date
The "Global Structural Biology & Molecular Modeling Market Analysis to 2027" is a specialized and in-depth study of the biotechnology industry with a focus on the global market trend. The report aims to provide an overview of global structural biology & molecular modeling market with detailed market segmentation by product, application and geography. The global Structural biology & molecular modeling market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading Structural biology & molecular modeling market players and offers key trends and opportunities in the market.
Leading Key Players
1. Acellera Ltd. 2. Agile Molecule 3. Dassault Systèmes 4. Bioinformatics Inc. 5. Agilent Technologies, Inc. 6. Illumina, Inc. 7. Bruker 8. Biomax Informatics AG 9. Chemical Computing Group 10. QIAGEN
The structural biology & molecular modeling market is anticipated to grow in the forecast period owing to key factor such as growth in drug development, rising demand for modeling techniques in order to reduce the probability of drug failure and rapid advancements in bioinformatics help in determination of accurate structures and predict cellular functions & interactions. Also the increasing in the incidences of lifestyle diseases with acquired drug resistance that exemplifies the need for new and advanced therapeutics.
The global structural biology & molecular modeling market is segmented on the basis of product, and application. Based on product, the structural biology & molecular modeling market is segmented SaaS & standalone modeling, visualization & analysis, databases and others. The SaaS & standalone modeling segment consists of homology modeling, threading, molecular dynamics, ab initio, hybrid, and others. Based on application, the structural biology & molecular modeling market is segmented as drug development, drug discovery and others.
The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the global Structural biology & molecular modeling market based on product, and application. It also provides market size and forecast till 2027 for overall market with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The structural biology & molecular modeling market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.
North America is expected to contribute to the largest share in the structural biology & molecular modeling market in the forecast period, due to presence of large number of well-established market players having robust R&D activities in the U.S. and growing drug designing to develop new treatment alternatives. However, Asia Pacific region is expected to be the fastest growing region owing to rising presence of contract research organizations, increasing adoption of healthcare IT, and unprecedented evolution of the healthcare infrastructure and standards.
The report analyzes factors affecting structural biology & molecular modeling market from both demand and supply side and further evaluates market dynamics effecting the market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the Structural biology & molecular modeling market in these regions.
The report also includes the profiles of key Structural biology & molecular modeling companies along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered, financial information of last 3 years, key development in past five years. Some of the key players operating in the structural biology & molecular modeling market include, Acellera Ltd., Agile Molecule, Dassault Systèmes, Bioinformatics Inc., Agilent Technologies, Inc., Illumina, Inc., Bruker, Biomax Informatics AG, Chemical Computing Group, and QIAGEN among others.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
